Skip to main content

Security report for lareb.nl

Bijwerkingencentrum Lareb · Healthcare · Netherlands

Low risk. 1 critical or high finding in GDPR outside view.

Security score

86/100

Risk levelLow

0–100, higher is better. How it is calculated

Bijwerkingencentrum Lareb is the Dutch national pharmacovigilance center dedicated to collecting and disseminating information on adverse reactions to medicines, vaccines, and health products. The website serves healthcare professionals, patients, and the general public, providing reporting mechanisms, research insights, and educational content focused on drug safety and pregnancy-related medication use. The organization operates as a non-profit entity with a strong national presence and trusted reputation in healthcare safety. Technically, the website employs modern web technologies including jQuery, Bootstrap, and Semantic UI for responsive design and user experience. It integrates Piwik PRO analytics for user tracking and captcha.at for bot protection, indicating a mature digital infrastructure. The site is well-optimized for mobile devices and accessibility, with clear navigation and professional design. From a security perspective, the site enforces HTTPS and uses CAPTCHA to mitigate automated abuse. However, it lacks explicit security policy documentation and incident response contact details, which are areas for improvement. No critical vulnerabilities or exposed sensitive data were detected. Privacy compliance is strong with clear privacy and cookie policies aligned with GDPR requirements. Overall, the website presents a low-risk profile with high trustworthiness and professional credibility. Strategic enhancements in security transparency and incident response readiness would further strengthen its posture.

Scanned

NIS2 and GDPR posture

GDPR outside view
68/ 100 · Medium
Checks completed
7of 7

NIS2 Art. 21(2)

  1. (a) Risk analysis and security policies: Not visible from outside
  2. (b) Incident handling: One indicator
  3. (c) Business continuity, backups and crisis management: Not visible from outside
  4. (d) Supply chain security: Not visible from outside
  5. (e) Secure acquisition, development and maintenance, including vulnerability handling: Partly checked
  6. (f) Assessing the effectiveness of security measures: Not visible from outside
  7. (g) Cyber hygiene and security training: Not visible from outside
  8. (h) Cryptography and encryption: Partly checked
  9. (i) HR security, access control and asset management: One indicator
  10. (j) Multi-factor authentication and secured communications: Not visible from outside

This scan rated NIS2 with an earlier keyword method that is no longer shown; rescan for the per-article view. Risk management, continuity, supply chain, training, MFA, management oversight (Art. 20) and incident reporting (Art. 23) need internal evidence, and Guard cannot tell whether NIS2 applies to this organisation.

GDPR is indicative only, based on publicly visible signals: Articles 7, 12, 13 and 32 of Regulation (EU) 2016/679 and Article 5(3) of the ePrivacy Directive. Not a certification or legal assessment.

Priority findings

1 finding rated critical or high. Fix these first.

  1. GDPR outside view

    These are the privacy signals visitors and data protection authorities look for under GDPR.

    • High

      No Cookie Consent Banner found

      GDPR requires explicit consent for non-essential cookies

      What to do: Implement a cookie consent banner that appears on first visit

Need hands-on remediation? Email guard@offseq.com

Keep watching lareb.nl

This scan found 13 issues across 6 checks. Monitoring re-runs those checks daily, emails you when something material changes and records each fix, so you can show progress.

Daily monitoring

Recommended

€25per month

  • TLS certificates and expiry
  • DNS records
  • SPF, DKIM and DMARC
  • Security headers
  • GDPR and NIS2 posture
  • Exposed services
  • Third-party trackers
  • Security score drift

Email alerts on material changes and an exportable JSON history of every change.

Billed monthly to your card. Cancel anytime. The full timeline opens with your unlock code.

Full report

€39.90one-time

  • The complete analysis as a PDF you can cite
  • Email delivery with an unlock code
  • Lifetime access to this report

Prices incl. 21% VAT. Secure checkout by Mollie; sold by SEQ SIA, Latvia.

Results by check

Each check with its score, findings and the evidence it collected.

How this score is calculated

The security score runs 0–100, higher is better. It is the plain average of the security checks that completed in this scan, each counted equally. A check that could not run is left out: it counts neither as a pass nor as a fail.

Counted in this score

SSL/TLS
95
Security headers
90
Email security
85
DNS health
75
Network security
100
GDPR outside view
68
Average
86

Not counted

  • NIS2 outside view: Re-weights evidence from the TLS, email, DNS, network and hygiene checks, so counting it would count that evidence twice. Shown on its own.
  • OffSeq Observations: An AI reading of the site, useful context but not reproducible evidence. Shown on its own.

Findings that cap the score at 49

Each of these is serious on its own, so while any is present the site cannot rate better than high risk, however good the other checks are.

  • The certificate is not trusted by browsers
  • The website is not served over HTTPS
  • A database, remote desktop, file-sharing or Telnet service is reachable from the internet
  • The page loads a script from a compromised source
  • The domain registration has expired
  • SPF authorises every server to send mail as the domain

Partial scans

When the site blocks Guard or most checks cannot run, the score covers only the checks that ran (usually DNS and email), is capped at 75 and is shown as partial, without a risk level.

Risk levels

  • Critical0–25
  • High26–49
  • Medium50–75
  • Low76–100

Technical appendix

Business context, site observations and technical notes gathered during the scan, and the standards behind each reference.

Business context

Business profile

Bijwerkingencentrum Lareb holds a key position in the Dutch healthcare ecosystem as the authoritative center for pharmacovigilance. Its business model focuses on non-profit public health service, relying on adverse event reporting and research to inform healthcare providers and patients. The organization targets healthcare professionals, pregnant women, and the general public concerned with medication safety. Its competitive advantage lies in its official status, comprehensive data collection, and trusted information dissemination. The website supports growth through educational content and social media engagement, fostering a broad partnership ecosystem with healthcare stakeholders.

Security posture

The website demonstrates a mature security posture with enforced HTTPS, bot protection via CAPTCHA, and privacy-conscious analytics configuration. However, the absence of published security policies and incident response contacts indicates gaps in transparency and preparedness. No vulnerabilities or insecure practices were observed in the HTML content. Compliance with GDPR is evident through privacy and cookie policies. To elevate security maturity, the organization should consider publishing formal security and incident response policies and implementing additional HTTP security headers.

Recommendations

  1. Publish a dedicated security policy page outlining security practices and commitments.
  2. Provide clear incident response contact channels such as security@ or abuse@ email addresses.
  3. Implement and configure HTTP security headers like Content-Security-Policy and X-Frame-Options.
  4. Consider publishing a vulnerability disclosure policy or security.txt file to encourage responsible reporting.
  5. Maintain and regularly review privacy and cookie policies to ensure ongoing GDPR compliance.
Site observations

Automated reading of the public site. Ratings are indicative.

Business

Company
Bijwerkingencentrum Lareb
Description
Het meld- en kenniscentrum voor bijwerkingen van geneesmiddelen, vaccins en gezondheidsproducten.
Key services
Adverse reaction reporting, Information dissemination on drug and vaccine side effects, Research on drug safety, Pregnancy-related medication information
Content quality
good
Branding
consistent

Technology

Stack
jQuery, Bootstrap, Semantic UI CSS, Piwik PRO analytics, Captcha.at anti-bot service
Frameworks
Bootstrap
Performance
moderate
Mobile
good
Accessibility
good
SEO
good

Security

Observed score
85/100
Good practices seen
  • HTTPS enforced
  • Use of CAPTCHA for bot protection
  • No exposed sensitive data in HTML
  • Use of analytics with cookie disabling option

Analytics and tracking

Services
Piwik PRO
Tracking level
moderate
Privacy practices
good

Advertising

Tracking pixels
Piwik PRO
Marketing tools
Piwik PRO analytics
Transparency
basic

Site quality

Design
good
User experience
good
Content relevance
good
Navigation
good
Professionalism
good
Trustworthiness
high

Key observations

  1. Website is fully accessible with no blocking or WAF challenges
  2. Content is professionally presented and relevant to pharmacovigilance and healthcare
  3. Multiple social media channels are linked and active
  4. Use of modern JavaScript libraries and analytics tools
  5. No direct company contact emails or phone numbers found in HTML; contact primarily via contact form
  6. No explicit security or incident response policies published
  7. Privacy and cookie policies are present and comprehensive
  8. No signs of suspicious or malicious content
Technical notes

Notes

The website uses a combination of jQuery, Bootstrap, and Semantic UI CSS frameworks to deliver a responsive and accessible user experience. Analytics are handled via Piwik PRO, with cookie disabling options to respect user privacy. CAPTCHA.at is integrated for bot mitigation. The site loads scripts asynchronously and defers non-critical JavaScript to optimize performance. No CMS is explicitly detected, suggesting a custom or proprietary platform. The site is moderately performant with good mobile optimization and SEO practices. Opportunities exist to enhance hosting transparency and implement advanced security headers.
Standards and sources

Reference chips under each finding point to the standard, regulation or specification the finding relates to. They are taken from the official datasets below and mapped conservatively: a finding with no defensible link shows none. NIS2 and GDPR references mark where a finding is relevant evidence, not a compliance verdict. Implementing Regulation (EU) 2024/2690 binds digital infrastructure and digital service providers; for other entities it is the most detailed public reading of the Article 21 measures. WCAG, EN 301 549, European Accessibility Act and Web Accessibility Directive references name the requirement an automated accessibility rule relates to; they are not a conformance verdict.

Retrieved 2026-10-25

Reviews of this site

Share your experience with lareb.nl. Every review is verified by email and published after moderation.

Overall rating
Select a rating
4000 characters remaining

We’ll email you to confirm your review and keep your details private.

Community rating

No published reviews yet. Be the first to review lareb.nl.

Feedback on this report

Rate this report, add an optional comment, and tell us if you want a security specialist to follow up.

Overall report quality
Select a rating
2000 characters remaining

We only use your feedback to improve Guard reports. Contact details are never shared.